Practice guidelines for the management of patients with histoplasmosis

Clinical Infectious Diseases

Volumn 30, Issue 4, 2000, Pages 688-695

  Wheat, Joe ^a   Sarosi, George ^a,b   Mc Kinsey, David ^c   Hamill, Richard ^d   Bradsher, Robert ^f   Johnson, Philip ^e   Loyd, James ^g   Kauffman, Carol ^h  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Infectious Disease Asociates of Kansas City   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^g VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CORTICOSTEROID; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE DISEASE; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; HIGH RISK POPULATION; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; INFECTIOUS ARTHRITIS; LUNG INFECTION; MEDIASTINITIS; MENINGITIS; MORBIDITY; NONHUMAN; PERICARDITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW;

ANTIFUNGAL AGENTS; ARTHRITIS; CENTRAL NERVOUS SYSTEM DISEASES; COST-BENEFIT ANALYSIS; FEMALE; HEALTH PLANNING GUIDELINES; HISTOPLASMA; HISTOPLASMOSIS; HUMAN; LUNG DISEASES; MEDIASTINITIS; OUTCOME ASSESSMENT (HEALTH CARE); PERICARDITIS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 0033800861     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313752     Document Type: Review

References (46)

1. Outbreak of histoplasmosis associated with the 1970 Earth Day activities
2. Practice guidelines for the treatment of fungal infections
3. Itraconazole maintenance treatment for histoplasmosis in AIDS: A prospective, multicenter trial
4. Acute pulmonary, histoplasmosis presenting as adult respiratory distress syndrome: Effect of therapy on clinical and laboratory features
5. The course and prognosis of histoplasmosis
6. Comparison of treated and untreated severe histoplasmosis
7. Treatment of chronic pulmonary histoplasmosis
8. Histoplasmosis cooperative study: Veterans Administration-Armed Forces Cooperative Study on histoplasmosis
9. Histoplasmosis cooperative study: Chronic pulmonary histoplasmosis treated with amphotericin B alone and with amphotericin B and triple sulfonamide
10. Follow-up of patients with chronic pulmonary histoplasmosis treated with amphotericin B
11. Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group
12. Treatment of blastomycosis and histoplasmosis with ketoconazole: Results of a prospective randomized clinical trial
13. Treatment of disseminated and progressive cavitary histoplasmosis with ketoconazole
14. Fluconazole therapy for histoplasmosis
15. Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome
16. Disseminated histoplasmosis in the acquired immune deficiency syndrome: Clinical findings, diagnosis and treatment, and review of the literature
17. Progressive disseminated histoplasmosis as seen in adults
18. Disseminated histoplasmosis: Results of long-term follow-up
19. Clinical and laboratory features of disseminated histoplasmosis during two large urban outbreaks
20. Histoplasmosis in the acquired immunodeficiency syndrome
21. Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial Group
22. Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. NIAID Clinical Trials and Mycoses Study Group Collaborators
23. Long-term amphotericin B therapy for disseminated histoplasmosis in patients with the acquired immune deficiency syndrome
24. Prevention of relapse of histoplasmosis with fluconazole in patients with the acquired immunodeficiency syndrome
25. Hypothesis on the mechanism of resistance to fluconazole in Histoplasma capsulatum
26. Histoplasmosis relapse in patients with AIDS: Detection using Histoplasma capsulatum variety capsulatum antigen levels
27. Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: Randomized, placebo-controlled, double-blind study
28. Histoplasma capsulatum infections of the central nervous system: A clinical review
29. Penetration of lipid formulations of amphotericin B into cerebrospinal fluid and brain tissue
30. Amphotericin B concentration in cerebrospinal fluid of patients with AIDS and cryptococcal meningitis
31. Liposomal amphotericin B (Am-Bisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis
32. Dysphagia due to mediastinal granulomas: Diagnosis with endoscopic ultrasonography
33. Fluconazole therapy in Histoplasma mediastinal granuloma
34. Tracheal obstruction secondary to Histoplasma mediastinal granuloma
35. Esophageal obstruction caused by mediastinal histoplasmosis: Beneficial results of operation
36. Mediastinal Histoplasma granuloma causing tracheal compression in a 4-year-old child
37. Surgical intervention in histoplasmosis
38. Mediastinal histoplasmosis granuloma: Evaluation with CT
39. Mediastinal fibrosis complicating histoplasmosis
40. Mediastinal fibrosis complicating healed primary histoplasmosis and tuberculosis
41. Sclerosing mediastinitis: Improved management with histoplasmosis titer and ketoconazole
42. Clinical manifestations of mediastinal fibrosis and histoplasmosis
43. Mediastinal granuloma and fibrosing mediastinitis
44. Pericarditis as a manifestation of histoplasmosis during two large urban outbreaks
45. Erythema nodosum in an epidemic of histoplasmosis in Indianapolis
46. An epidemic of erythema multiforme and erythema nodosum caused by histoplasmosis